Choose language / Korean

Join Telegram

Bayer (BAYRY), 'Nubeqa' shows 71% risk reduction…Secures successive FDA priority reviews
Bull/Bear Index 45.5/100
crypto BULL 55/10 TokenPost · 1h ago

Bayer (BAYRY), 'Nubeqa' shows 71% risk reduction…Secures successive FDA priority reviews

Bayer is strengthening its presence in the global pharmaceutical market by announcing positive clinical results for its prostate cancer drug 'Nubeqa' and securing multiple FDA priority reviews.

Catch the next bull catalyst

Telegram alerts when our AI scores a story 8+/10 (~1-3 per day, no spam). Verified 30d hit rate 50.1%.

Join Telegram channel

📡 Tomorrow's Watch

Related news


40/10

An analytical article discussing the possibility of Solana surpassing Ethereum's market dominance by 2028.

#crypto

25/10 +1

An article discussing estimates for how much Ethereum one might need to retire by 2040.

#crypto

35/10 +1

An article discussing the amount of Ethereum needed to retire by 2040, covering the potential long-term value and speculative nature of Ethereum as a retirement asset.

#crypto

50/10

Former President Trump claimed he 'saved' the crypto market, but the article questions whether major cryptocurrencies like Bitcoin, Ethereum, and XRP actually benefited directly from his actions or statements.

#crypto

35/10 +1

$1.47 million worth of Satoshi-era Bitcoin moved after nearly 16 years.

#crypto

BEAR 45/10 +1

$1.47 Million in Satoshi Era Bitcoin Moves After Nearly 16 Years.

#crypto